Index S&P 500
P/E 19.91
EPS (ttm) 26.46
Insider Own 0.50%
Shs Outstand 233.07M
Perf Week -1.92%
Market Cap 122.48B
Forward P/E 12.66
EPS next Y 41.63
Insider Trans -4.29%
Shs Float 231.26M
Perf Month 5.69%
Income 6.24B
PEG 1.65
EPS next Q 10.03
Inst Own 91.49%
Short Float 0.84%
Perf Quarter 6.43%
Sales 171.75B
P/S 0.71
EPS this Y 12.46%
Inst Trans 0.08%
Short Ratio 1.99
Perf Half Y 17.98%
Book/sh 174.62
P/B 3.02
EPS next Y 11.71%
ROA 5.65%
Short Interest 1.94M
Perf Year 15.01%
Cash/sh -
P/C -
EPS next 5Y 12.10%
ROE 16.02%
52W Range 412.00 - 542.07
Perf YTD 11.75%
Dividend Est. 6.24 (1.18%)
P/FCF 53.34
EPS past 5Y 12.18%
ROI 9.98%
52W High -2.79%
Beta 0.84
Dividend TTM 6.07 (1.15%)
Quick Ratio -
Sales past 5Y 13.24%
Gross Margin -
52W Low 27.90%
ATR (14) 9.04
Dividend Ex-Date Jun 10, 2024
Current Ratio 1.37
EPS Y/Y TTM 2.51%
Oper. Margin 5.29%
RSI (14) 55.97
Volatility 1.44% 1.70%
Employees 104900
Debt/Eq 0.65
Sales Y/Y TTM 6.89%
Profit Margin 3.64%
Recom 1.50
Target Price 606.54
Option/Short Yes / Yes
LT Debt/Eq 0.54
EPS Q/Q 15.57%
Payout 23.47%
Rel Volume 0.84
Prev Close 525.61
Sales Surprise -0.52%
EPS Surprise 1.15%
Sales Q/Q 0.96%
Earnings Apr 18 BMO
Avg Volume 974.96K
Price 526.96
SMA20 1.33%
SMA50 2.69%
SMA200 10.14%
Trades
Volume 819,413
Change 0.26%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
Barclays
Overweight
$584
Jul-12-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Apr-27-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$500 → $571
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$547
Mar-28-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$523 → $572
Sep-09-22 Upgrade
BofA Securities
Neutral → Buy
$535 → $575
Aug-22-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$490 → $580
May-01-24 09:30AM
Apr-29-24 05:22PM
Apr-26-24 09:50AM
02:25AM
Apr-25-24 05:16PM
12:00PM
Loading…
12:00PM
Apr-24-24 09:45AM
Apr-23-24 09:40AM
Apr-22-24 07:00AM
(The Wall Street Journal)
Apr-19-24 09:32AM
03:02AM
01:01AM
Apr-18-24 11:49PM
(Thomson Reuters StreetEvents)
04:27PM
03:53PM
12:15PM
Loading…
12:15PM
11:58AM
11:18AM
10:53AM
10:45AM
(The Wall Street Journal)
09:41AM
09:30AM
08:15AM
07:10AM
06:17AM
06:09AM
(Associated Press Finance)
06:03AM
06:00AM
Apr-17-24 10:33AM
Apr-16-24 06:25PM
(The Wall Street Journal)
12:13PM
Loading…
12:13PM
Apr-15-24 04:17PM
11:28AM
09:19AM
07:00AM
Apr-11-24 10:00AM
Apr-09-24 02:13PM
Apr-06-24 07:00PM
Apr-03-24 04:51PM
12:10PM
Apr-02-24 05:23PM
(The Wall Street Journal)
04:41PM
04:01PM
(Investor's Business Daily)
10:39AM
07:20AM
07:02AM
(The Wall Street Journal)
Apr-01-24 11:17AM
Mar-31-24 11:03PM
Mar-30-24 06:50AM
Mar-28-24 04:05PM
03:22PM
(The Wall Street Journal)
Mar-26-24 05:25PM
Mar-25-24 04:44PM
08:39AM
Mar-22-24 06:15PM
Mar-21-24 08:02PM
02:08AM
Mar-20-24 09:21AM
Mar-19-24 03:35PM
11:53AM
Mar-18-24 06:23PM
(The Wall Street Journal)
04:50PM
04:48PM
04:19PM
Mar-17-24 12:55PM
Mar-15-24 12:57PM
Mar-14-24 06:15PM
Mar-13-24 09:30AM
Mar-12-24 11:16AM
Mar-11-24 07:13AM
06:15AM
06:15AM
Mar-06-24 05:02AM
Mar-05-24 06:15PM
04:02AM
Mar-02-24 10:42AM
Feb-28-24 09:10AM
Feb-24-24 12:09AM
Feb-23-24 11:30AM
Feb-22-24 06:15PM
04:30PM
04:05PM
Feb-19-24 09:40AM
Feb-17-24 01:29PM
Feb-15-24 04:05AM
Feb-14-24 08:13PM
01:42PM
Feb-13-24 04:45AM
Feb-05-24 04:03PM
11:30AM
Feb-02-24 09:40AM
Jan-28-24 01:14PM
Jan-25-24 10:51AM
10:06AM
(The Wall Street Journal)
Jan-24-24 11:51PM
(Thomson Reuters StreetEvents)
02:30PM
01:31PM
01:05PM
11:23AM
10:15AM
(The Wall Street Journal)
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Option Exercise 238.27 2,043 486,786 33,503 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Sale 532.44 6,199 3,300,590 27,304 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Option Exercise 238.27 5,473 1,304,052 45,571 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Sale 533.74 14,111 7,531,565 31,460 Apr 25 05:05 PM Kendrick Charles Morgan JR EVP & President, Commercial Mar 08 '24 Sale 500.46 2,432 1,217,119 15,840 Mar 12 04:26 PM Penczek Ronald W CAO & Controller Mar 06 '24 Sale 504.58 916 462,195 1,764 Mar 08 04:16 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Option Exercise 166.97 15,000 2,504,550 39,982 Mar 05 04:24 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Sale 500.18 21,095 10,551,297 18,887 Mar 05 04:24 PM PERU RAMIRO G Director Feb 07 '24 Sale 500.00 753 376,500 9,109 Feb 09 04:22 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Option Exercise 311.48 5,492 1,710,648 18,004 Dec 15 04:28 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Sale 484.02 5,492 2,658,238 12,512 Dec 15 04:28 PM Penczek Ronald W CAO & Controller Nov 30 '23 Sale 475.17 1,055 501,304 1,787 Dec 01 04:21 PM Penczek Ronald W CAO & Controller Oct 24 '23 Sale 454.35 64 29,078 2,842 Oct 26 04:15 PM Dixon Robert L JR Director Jul 21 '23 Sale 476.71 310 147,780 9,638 Jul 21 05:01 PM
Index S&P 500
P/E 12.50
EPS (ttm) 4.79
Insider Own 0.15%
Shs Outstand 3.60B
Perf Week 0.05%
Market Cap 208.97B
Forward P/E 10.91
EPS next Y 5.50
Insider Trans 0.07%
Shs Float 3.48B
Perf Month 5.75%
Income 17.58B
PEG 1.87
EPS next Q 1.27
Inst Own 79.22%
Short Float 0.93%
Perf Quarter 21.93%
Sales 120.67B
P/S 1.73
EPS this Y 3.81%
Inst Trans 1.40%
Short Ratio 1.71
Perf Half Y 51.33%
Book/sh 105.68
P/B 0.57
EPS next Y 9.61%
ROA 0.98%
Short Interest 32.50M
Perf Year 55.08%
Cash/sh -
P/C -
EPS next 5Y 6.67%
ROE 6.59%
52W Range 36.40 - 61.76
Perf YTD 21.78%
Dividend Est. 1.48 (2.46%)
P/FCF 5.97
EPS past 5Y 2.48%
ROI 3.12%
52W High -2.95%
Beta 1.18
Dividend TTM 1.35 (2.25%)
Quick Ratio -
Sales past 5Y 6.37%
Gross Margin -
52W Low 64.67%
ATR (14) 1.11
Dividend Ex-Date May 09, 2024
Current Ratio 1.05
EPS Y/Y TTM 37.04%
Oper. Margin 19.15%
RSI (14) 61.78
Volatility 1.49% 1.98%
Employees 226000
Debt/Eq 0.77
Sales Y/Y TTM 14.41%
Profit Margin 14.57%
Recom 2.23
Target Price 63.53
Option/Short Yes / Yes
LT Debt/Eq 0.45
EPS Q/Q -2.93%
Payout 26.90%
Rel Volume 0.86
Prev Close 59.83
Sales Surprise 3.23%
EPS Surprise 12.57%
Sales Q/Q 12.52%
Earnings Apr 12 BMO
Avg Volume 19.00M
Price 59.94
SMA20 2.16%
SMA50 4.40%
SMA200 25.48%
Trades
Volume 16,253,502
Change 0.18%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-09-24 Downgrade
Compass Point
Buy → Neutral
$64
Mar-27-24 Downgrade
Keefe Bruyette
Outperform → Mkt Perform
$56 → $62
Jan-18-24 Downgrade
Odeon
Buy → Hold
Jan-09-24 Downgrade
Deutsche Bank
Buy → Hold
$51
Jan-08-24 Downgrade
Robert W. Baird
Outperform → Neutral
$55
Dec-14-23 Upgrade
Odeon
Hold → Buy
Sep-07-23 Initiated
HSBC Securities
Hold
$45
Jul-17-23 Downgrade
Odeon
Buy → Hold
$43.75
Jul-07-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Jul-03-23 Reiterated
Raymond James
Strong Buy
$48 → $51
Jun-08-23 Downgrade
Odeon
Buy → Hold
$44.60
Apr-06-23 Upgrade
Raymond James
Outperform → Strong Buy
$52 → $47
Mar-13-23 Downgrade
Odeon
Buy → Hold
Jan-17-23 Downgrade
Piper Sandler
Overweight → Neutral
$49 → $47
Jan-17-23 Downgrade
Jefferies
Buy → Hold
$49 → $46
Jan-10-23 Upgrade
Odeon
Hold → Buy
$51.79
Oct-03-22 Upgrade
Goldman
Neutral → Buy
$46 → $48
Apr-11-22 Upgrade
Citigroup
Neutral → Buy
Feb-01-22 Upgrade
Atlantic Equities
Neutral → Overweight
$60
Jan-12-22 Upgrade
Piper Sandler
Neutral → Overweight
$50 → $64
Show Previous Ratings
May-04-24 11:02AM
10:54AM
10:11AM
10:11AM
10:05AM
09:30AM
Loading…
09:30AM
07:38AM
May-03-24 06:29PM
04:23PM
04:22PM
04:12PM
04:07PM
04:06PM
04:06PM
04:04PM
03:51PM
Loading…
03:51PM
02:05PM
01:04PM
12:52PM
12:47PM
12:34PM
12:23PM
12:20PM
11:39AM
10:54AM
10:39AM
01:08AM
May-02-24 04:07PM
04:04PM
04:02PM
03:57PM
Loading…
03:57PM
03:36PM
01:53PM
01:13PM
01:08PM
12:20PM
11:24AM
11:18AM
10:41AM
09:26AM
08:54AM
May-01-24 12:47PM
12:45PM
12:30PM
12:28PM
12:19PM
11:21AM
10:13AM
09:15AM
09:07AM
09:00AM
08:25AM
Apr-30-24 07:17PM
07:15PM
04:14PM
03:00PM
02:43PM
02:17PM
02:03PM
01:30PM
01:12PM
12:30PM
12:10PM
12:01PM
10:48AM
09:47AM
08:50AM
08:38AM
08:30AM
05:32AM
04:00AM
Apr-29-24 04:30PM
06:05AM
Apr-27-24 08:49AM
Apr-26-24 01:40PM
08:49AM
Apr-25-24 10:02PM
08:49PM
06:19PM
03:01PM
01:27PM
10:57AM
10:25AM
09:00AM
07:08AM
Apr-24-24 12:19PM
12:19PM
11:36AM
11:25AM
11:24AM
11:22AM
11:16AM
10:53AM
10:42AM
10:40AM
10:34AM
09:43AM
08:10AM
Apr-23-24 12:38PM
12:00PM
Wells Fargo & Co. is a diversified, community-based financial services company. It is engaged in the provision of banking, insurance, investments, mortgage products and services, and consumer and commercial finance. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth & Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment offers banking and credit products across multiple industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment offers corporate banking, investment banking, treasury management, commercial real estate lending and servicing, equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth & Investment Management segment provides personalized wealth management, brokerage, financial planning, lending, private banking, trust and fiduciary products and services to affluent, high-net worth and ultra-high-net worth clients. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kerrins Tracy M SR. EXECUTIVE VICE PRESIDENT Mar 15 '24 Option Exercise 0.00 5,956 0 19,851 Mar 19 04:50 PM DALEY WILLIAM M Vice Chairman - Public Affairs Mar 05 '24 Option Exercise 0.00 63,051 0 83,501 Mar 07 08:13 PM Powell Scott SEVP & Chief Operating Officer Mar 05 '24 Option Exercise 0.00 130,852 0 308,610 Mar 07 08:13 PM Van Beurden Saul Sr. Executive Vice President Mar 05 '24 Option Exercise 0.00 70,494 0 197,492 Mar 07 08:12 PM Weiss Jonathan G. Sr. Executive Vice President Mar 05 '24 Option Exercise 0.00 125,087 0 437,807 Mar 07 08:12 PM Williams Ather III Sr. Executive Vice President Mar 05 '24 Option Exercise 0.00 93,990 0 271,323 Mar 07 08:21 PM SCHARF CHARLES W CEO & President Mar 05 '24 Option Exercise 0.00 316,864 0 974,894 Mar 07 08:19 PM Flowers Derek A. Sr. EVP and Chief Risk Officer Mar 05 '24 Option Exercise 0.00 44,058 0 70,850 Mar 07 08:19 PM Sommers Barry Sr. Executive Vice President Mar 05 '24 Option Exercise 0.00 64,618 0 115,562 Mar 07 08:17 PM Patterson Ellen R Sr. EVP and General Counsel Mar 05 '24 Option Exercise 0.00 88,116 0 182,539 Mar 07 08:15 PM Santomassimo Michael P. Sr. EVP & CFO Mar 05 '24 Option Exercise 0.00 176,231 0 397,356 Mar 07 08:15 PM Chancy Mark A Director Mar 01 '24 Option Exercise 55.06 3,253 179,110 25,705 Mar 05 08:34 PM Carr Muneera S EVP, CAO & Controller Feb 05 '24 Option Exercise 0.00 44,152 0 64,754 Feb 07 06:42 PM DALEY WILLIAM M Vice Chairman - Public Affairs Feb 05 '24 Option Exercise 0.00 39,770 0 26,859 Feb 07 06:45 PM Hranicky Kyle G Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 43,426 0 43,308 Feb 07 07:00 PM Flowers Derek A. Sr. EVP and Chief Risk Officer Feb 05 '24 Option Exercise 0.00 47,918 0 33,403 Feb 07 06:54 PM Fercho Kristy Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 22,022 0 52,302 Feb 07 06:50 PM Powell Scott SEVP & Chief Operating Officer Feb 05 '24 Option Exercise 0.00 74,270 0 189,158 Feb 07 07:16 PM Santomassimo Michael P. Sr. EVP & CFO Feb 05 '24 Option Exercise 0.00 96,845 0 235,617 Feb 07 07:19 PM Santos Kleber Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 21,725 0 37,547 Feb 07 07:24 PM Patterson Ellen R Sr. EVP and General Counsel Feb 05 '24 Option Exercise 0.00 57,751 0 105,657 Feb 07 07:10 PM Ling Bei Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 17,307 0 46,357 Feb 07 07:07 PM Kerrins Tracy M Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 22,809 0 17,738 Feb 07 07:03 PM SCHARF CHARLES W CEO & President Feb 05 '24 Option Exercise 0.00 159,807 0 682,908 Feb 07 07:28 PM Sommers Barry Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 56,423 0 62,615 Feb 07 07:31 PM Weiss Jonathan G. Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 91,805 0 330,982 Feb 07 07:41 PM Van Beurden Saul Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 58,655 0 139,194 Feb 07 07:35 PM Williams Ather III Sr. Executive Vice President Feb 05 '24 Option Exercise 0.00 52,734 0 185,931 Feb 07 07:58 PM Powell Scott SEVP & Chief Operating Officer Jan 28 '24 Option Exercise 0.00 35,208 0 156,430 Jan 30 04:15 PM Ling Bei Sr. Executive Vice President Jan 15 '24 Option Exercise 0.00 19,017 0 42,221 Jan 17 04:25 PM DAVIS RICHARD K Director Nov 09 '23 Buy 41.22 3,500 144,270 4,244 Nov 09 04:20 PM SCHARF CHARLES W CEO & President Oct 21 '23 Option Exercise 0.00 127,050 0 656,856 Oct 24 04:21 PM Fercho Kristy Sr. Executive Vice President Oct 08 '23 Option Exercise 0.00 3,705 0 38,979 Oct 11 05:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite